Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor

Molecular Brain Research

Volumn 52, Issue 2, 1997, Pages 182-193

  Sydow, Sabine ^a   Radulovic, Jelena ^a   Dautzenberg, Frank M ^a   Spiess, Joachim ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

CHO K1 cell; Corticotropin releasing factor receptor; CRF binding; CRFR1 antibodies; Cyclic AMP; HEK293 cell; Histidine tag; N glycosylation

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; HISTIDINE; POLYCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISSOCIATION CONSTANT; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; RAT; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL MEMBRANE; CHO CELLS; CORTICOTROPIN-RELEASING HORMONE; CRICETINAE; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; RADIOLIGAND ASSAY; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECOMBINANT PROTEINS; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

ANIMALIA; ESCHERICHIA COLI; MAMMALIA;

EID: 0031574347     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00256-8     Document Type: Article

References (46)

1. [1] J. Alblas, I. van Etten, A. Khanum, W.H. Moolenaar, C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signaling. Role of receptor phosphorylation in signal attenuation, J. Biol. Chem. 270 (1995) 8944-8951.
2. [2] R.V. Benya, Z. Fathi, J.F. Battey, R.T. Jensen, Serines and threonines in the gastrin-releasing peptide receptor carboxyl-terminus mediate internalization, J. Biol. Chem. 268 (1993) 20285-20290.
3. [3] M.G. Castro, E. Morrison, M.J. Perone, O.A. Brown, C.A. Murray, I. Ahmed, A.V. Perkins, G. Europe-Finner, P.R. Lowenstein, E.A. Linton, Corticotrophin-releasing hormone receptor type 1: generation and characterization of polyclonal antipeptide antibodies and their localization in pituitary cells and cortical neurones in vitro, J. Neuroendocrinol. 8 (1996) 521-531.
4. [4] C.P. Chang, R.V.D. Pearse, S. O'Connell, M.G. Rosenfeld, Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain, Neuron 11 (1993) 1187-1195.
5. [5] R. Chen, K.A. Lewis, M.H. Perrin, W.W. Vale, Expression cloning of a human corticotropin-releasing-factor receptor, Proc. Natl. Acad. Sci. USA 90 (1993) 8967-8971.
6. [6] L.J. Crofford, H. Sano, K. Karalis, T.C. Friedman, H.R. Epps, E.F. Remmers, P. Mathern, G.P. Chrousos, R.L. Wilder, Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis, J. Immunol. 151 (1993) 1587-1596.
7. [7] E.B. De Souza, T.R. Insel, M.H. Perrin, J. Rivier, W.W. Vale, M.J. Kuhar, Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study, J. Neurosci. 5 (1985) 3189-3203.
8. [8] A.J. Dunn, C.W. Berridge, Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?, Brain Res. Rev. 15 (1990) 71-100.
9. [9] D.M. Findlay, S. Houssami, H.Y. Lin, D.E. Myers, C.L. Brady, P.K. Darcy, K. Ikeda, T.J. Martin, P.M. Sexton, Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity, Mol. Endocrinol. 8 (1994) 1691-1700.
10. [10] M. Flores, P. Carvallo, G. Aguilera, Physicochemical characterization of corticotrophin releasing factor receptor in rat pituitary and brain, Life Sci. 47 (1990) 2035-2040.
11. [11] J.M. Gibbins, R.J. Woods, P.J. Lowry, Affinity purification of 61-and 65-kDa rat brain corticotropin-releasing factor receptors and receptor-associated G proteins, Int. J. Biochem. Cell Biol. 28 (1996) 1017-1029.
12. [12] F.L. Graham, J. Smiley, W.C. Russell, R. Nairn, Characteristics of a human cell line transformed by DNA from human adenovirus type 5, J. Gen. Virol. 36 (1977) 59-72.
13. [13] D.E. Grigoriadis, E.B. De Souza, The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies, J. Biol. Chem. 263 (1988) 10927-10931.
14. [14] D.E. Grigoriadis, E.B. De Souza, Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization, Peptides 10 (1989) 179-188.
15. [15] D.E. Grigoriadis, E.B. De Souza, Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation, Endocrinology 125 (1989) 1877-1888.
16. [16] D.E. Grigoriadis, J.A. Heroux, E.B. De Souza, Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems, Ciba Found. Symp. 172 (1993) 85-101.
17. [17] D.E. Grigoriadis, R.G. Struble, D.L. Price, E.B. De Souza, Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies, Neuropharmacology 28 (1989) 761-764.
18. [18] R.L. Hauger, F.M. Dautzenberg, A. Flaccus, T. Liepold, J. Spiess, Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery, J. Neurochem. 68 (1997) 2308-2316.
19. [19] R.W. Hipkin, X. Liu, M. Ascoli, Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist-or phorbol ester-induced receptor phosphorylation and uncoupling, J. Biol. Chem. 270 (1995) 26683-26689.
20. [20] K. Karalis, H. Sano, J. Redwine, S. Listwak, R.L. Wilder, G.P. Chrousos, Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo, Science 254 (1991) 421-423.
21. [21] T. Kishimoto, R.V.N. Pearse, C.R. Lin, M.G. Rosenfeld, A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle, Proc. Natl. Acad. Sci. USA 92 (1995) 1108-1112.
22. [22] A.K.E. Köpke, I. Bonk, S. Sydow, H. Menke, J. Spiess, Characterization of the NR1, NR2A, and NR2C receptor proteins, Prot. Sci. 2 (1993) 2066-2076.
23. [23] T. Koshimizu, G. Tsujimoto, K. Ono, T. Masaki, A. Sakamoto, Truncation of the receptor carboxyl terminus impairs membrane signaling but not ligand binding of human ETB endothelin receptor, Biochem. Biophys Res. Commun. 217 (1995) 354-362.
24. [24] T.W. Lovenberg, D.T. Chalmers, C. Liu, E.B. De Souza, CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues, Endocrinology 136 (1995) 4139-4142.
25. [25] T.W. Lovenberg, C.W. Liaw, D.E. Grigoriadis, W. Clevenger, D.T. Chalmers, E.B. De Souza, T. Oltersdorf, Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain, Proc. Natl. Acad. Sci. USA 92 (1995) 836-840.
26. [26] E. Nishimura, N. Billestrup, M. Perrin, W. Vale, Identification and characterization of a pituitary corticotropin-releasing factor binding protein by chemical cross-linking, J. Biol. Chem. 262 (1987) 12893-12896.
27. [27] M.C. Olianas, G. Lampis, P. Onali, Human Y-79 retinoblastoma cells express functional corticotropin-releasing hormone receptors, Brain Res. 593 (1992) 304-306.
28. [28] M.C. Olianas, G. Lampis, P. Onali, Human Y-79 retinoblastoma cells exhibit specific corticotropin-releasing hormone binding sites, J. Neurochem. 64 (1995) 402-407.
29. [29] M.C. Olianas, P. Onali, G protein-coupled corticotropin-releasing hormone receptors in rat retina, Regul. Peptides 56 (1995) 61-70.
30. [30] J.J. Owens, C.B. Nemeroff, Physiology and pharmacology of corticotropin-releasing factor, Pharmacol. Rev. 43 (1991) 425-473.
31. [31] M. Perrin, C. Donaldson, R. Chen, A. Blount, T. Berggren, L. Bilezikjian, P. Sawchenko, W. Vale, Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart, Proc. Natl. Acad. Sci. USA 92 (1995) 2969-2973.
32. [32] M.H. Perrin, C.J. Donaldson, R. Chen, K.A. Lewis, W.W. Vale, Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor, Endocrinology 133 (1993) 3058-3061.
33. [33] B.E. Rosendale, D.B. Jarrett, A.G. Robinson, Identification of a corticotropin-releasing factor-binding protein in the plasma membrane of AtT-20 mouse pituitary tumor cells and its regulation by dexamethasone, Endocrinology 120 (1987) 2357-2366.
34. [34] A. Rühmann, A.K.E. Köpke, F.M. Dautzenberg, J. Spiess, Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling, Proc. Natl. Acad. Sci. USA 93 (1996) 10609-10613.
35. [35] J. Sambrook, E.F. Fritsch, T. Maniatis (Eds.), Molecular cloning: a laboratory manual, 2nd ed., Cold Spring Harbor Laboratory Press, New York, 1989, pp. 16.32-16.36.
36. [36] J. Spiess, J. Rivier, C. Rivier, W. Vale, Primary structure of corticotropin-releasing factor from ovine hypothalamus, Proc. Natl. Acad. Sci. USA 78 (1981) 6517-6521.
37. [37] P. Stenzel, R. Kesterson, W. Yeung, R.D. Cone, M.B. Rittenberg, M.P. Stenzel-Poore, Identification of a novel murine receptor for corticotropin-releasing hormone expressed in heart, Mol. Endocrinol. 9 (1995) 637-645.
38. [38] S. Sydow, A.K.E. Köpke, T. Blank, J. Spiess, Overexpression of a functional NMDA receptor subunit (NMDAR1) in baculovirus-infected Trichoplusia ni insect cells, Mol. Brain Res. 41 (1996) 228-240.
39. 1A receptor in CHO-K1 cells. The carboxyl-terminal region directs agonist-induced internalization but not receptor signaling or desensitization, J. Biol. Chem. 270 (1995) 207-213.
40. [40] G.G. Unson, A.M. Cypess, H.N. Kim, P.K. Goldsmith, C.J. Carruthers, R.B. Merrifield, T.P. Sakmar, Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding, J. Biol. Chem. 270 (1995) 27720-27727.
41. [41] W. Vale, J. Spiess, C. Rivier, J. Rivier, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin, Science 213 (1981) 1394-1397.
42. [42] N.C. Vamvakopoulos, T.O. Sioutopoulou, Z. Mamuris, P. Marcoulatos, P.C. Avgerinos, Regulation of corticotropin releasing hormone receptor type 1 messenger RNA level in Y-79 retinoblastoma cells: potential implications for human stress response and immune/inflammatory reaction, Mediators Inflamm. 5 (1996) 328-333.
43. [43] N. Vita, P. Laurent, S. Lefort, P. Chalon, J.M. Lelias, M. Kaghad, G. Le Fur, D. Caput, P. Ferrara, Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors, FEBS Lett. 335 (1993) 1-5.
44. [44] E.L. Webster, D.E. Grigoriadis, E.B. De Souza, Corticotropin-releasing factor receptors in the brain-pituitary-immune axis, in: J.A. McCubbin, P.G. Kaufmann, C.B. Nemeroff (Eds.), Stress, Neuropeptides, and Systemic Disease, Academic Press, San Diego, CA, 1991, pp. 233-260.
45. [45] P.C. Wynn, G. Aguilera, J. Morell, K.J. Catt, Properties and regulation of high-affinity pituitary recetors for corticotropin-releasing factor, Biochem. Biophys. Res. Commun. 110 (1983) 602-608.
46. [46] J. Yu, L.Y. Xie, A.-B. Abou-Samra, Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I, Endocrinology 137 (1996) 192-197.